Prognosis and therapy predictive markers and methods of use
US7892740B2 · kind B2 · utility
13Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2007 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Apr 8, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.